NO920855L - MEDICINE-CONTAINING MATRIX - Google Patents

MEDICINE-CONTAINING MATRIX

Info

Publication number
NO920855L
NO920855L NO92920855A NO920855A NO920855L NO 920855 L NO920855 L NO 920855L NO 92920855 A NO92920855 A NO 92920855A NO 920855 A NO920855 A NO 920855A NO 920855 L NO920855 L NO 920855L
Authority
NO
Norway
Prior art keywords
patient
lollipop
drug
lipophilic
medicine
Prior art date
Application number
NO92920855A
Other languages
Norwegian (no)
Other versions
NO920855D0 (en
Inventor
Theodore Stanley
Brian Hague
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Publication of NO920855D0 publication Critical patent/NO920855D0/en
Publication of NO920855L publication Critical patent/NO920855L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to methods and compositions for noninvasively administering lipophilic drugs in a dose-to-effect manner to produce antimigraine, oxytoxic, antiemetic, hypoglycemic, anti-Parkinsonian, antidiuretic, antifungal, antisecretory, or bronchodilator activity. A patient is put at ease when given the lollipop, and the lipophilic drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and terminate the use of the lollipop when it has had a desired effect on the patient. The drug-containing lollipop can be self-administered by the patient in response to subjective symptoms and to the patient's susceptibility to the lipophilic drug.
NO92920855A 1989-09-05 1992-03-04 MEDICINE-CONTAINING MATRIX NO920855L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs

Publications (2)

Publication Number Publication Date
NO920855D0 NO920855D0 (en) 1992-03-04
NO920855L true NO920855L (en) 1992-04-10

Family

ID=22215208

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92920854A NO920854L (en) 1989-09-05 1992-03-04 METHOD AND COMPOSITIONS FOR NON-INVASIVE DOSE FOR EFFECT ADMINISTRATION OF LIPOFILE MEDICINES
NO92920855A NO920855L (en) 1989-09-05 1992-03-04 MEDICINE-CONTAINING MATRIX

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO92920854A NO920854L (en) 1989-09-05 1992-03-04 METHOD AND COMPOSITIONS FOR NON-INVASIVE DOSE FOR EFFECT ADMINISTRATION OF LIPOFILE MEDICINES

Country Status (8)

Country Link
EP (1) EP0493380B1 (en)
JP (1) JP2758985B2 (en)
AT (1) ATE159658T1 (en)
AU (2) AU645966B2 (en)
DE (1) DE68928415T2 (en)
DK (1) DK175773B1 (en)
NO (2) NO920854L (en)
WO (1) WO1991003233A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (en) * 1977-08-05 1981-07-15 Battelle Memorial Institute
DK0745380T3 (en) * 1995-05-11 2005-12-05 Univ Utah Res Found tobacco Damages
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
WO2007090113A2 (en) * 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
RU2701199C2 (en) 2014-10-01 2019-09-25 Окситон Байосайенс Б.В. Orally disintegrating solid pharmaceutical dosage unit containing partus control substance
ES2821822T3 (en) 2014-10-01 2021-04-27 Oxytone Bioscience B V Solid oral disintegrating pharmaceutical dosage unit containing a birth control substance
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
EP3955918A1 (en) 2019-04-17 2022-02-23 COMPASS Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Also Published As

Publication number Publication date
NO920855D0 (en) 1992-03-04
WO1991003233A1 (en) 1991-03-21
AU5035290A (en) 1991-04-08
AU645966B2 (en) 1994-02-03
JP2758985B2 (en) 1998-05-28
DK175773B1 (en) 2005-02-14
JPH05501854A (en) 1993-04-08
DK30092A (en) 1992-05-05
NO920854D0 (en) 1992-03-04
EP0493380A1 (en) 1992-07-08
ATE159658T1 (en) 1997-11-15
EP0493380B1 (en) 1997-10-29
DK30092D0 (en) 1992-03-05
AU6069794A (en) 1994-06-23
EP0493380A4 (en) 1992-10-07
DE68928415D1 (en) 1997-12-04
NO920854L (en) 1992-04-27
DE68928415T2 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
Kennedy et al. Intravenous regional analgesia: an appraisal
DE69815122D1 (en) SACCHARID-CONTAINING PREPARATIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES
UY26425A1 (en) FORMULATION AND ANTI-DIABETIC METHOD
ES2186693T3 (en) COMBINED USE OF HIALURONIC ACID AND THERAPEUTIC AGENTS TO IMPROVE THE THERAPEUTIC EFFECT.
ATE111733T1 (en) USE OF NICOTINE TO MANUFACTURE A KIT FOR THE TREATMENT OF DISEASE CONDITIONS RESPONSIVE TO NICOTINE TREATMENT.
CA2041579A1 (en) Dosage form
DE799037T1 (en) METHOD AND MEANS FOR TREATING ALLERGIC RHINITIS AND OTHER DISEASES BY MEANS OF DESCARBOETHOXYLORATADINE
JP2002532432A5 (en)
NO920855D0 (en) MEDICINE-CONTAINING MATRIX
IL112288A (en) Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases
BR9708388A (en) Aqueous solution of pyridoxylated polymerized hemoglobin and the process for its preparation.
ATE89737T1 (en) TREATMENT OF LEUKOCYTE DISORDERS WITH GM-CSF.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
Duhault et al. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
CN2233753Y (en) Heart protective bag
Reynolds et al. Circulatory versus respiratory deaths from pentothal sodium
CN2224631Y (en) Health-care bag with medicines
RU94018748A (en) Medicinal species for treatment of patients with cardiac rhythm disorder
王小马 ELECTROIMPULSE ACUPUNCTURE TREATMENT OF 110 CASES OF ABDOMINAL PAIN AS A SEOUELA OF ABDOMINAL SURGERY
CN2219134Y (en) Chinese medicine treatment health bag
姚尊华 et al. OBSERVATION ON 52 CASES OF PARALYSIS OF COMMON PERONEAL NERVE TREATED BY ACUPUNCTURE AND PLUM-BLOSSOM NEEDLING
RU93034329A (en) MEDICINAL COLLECTION FOR TREATMENT OF VENTRICULAR EXTRASISTOLIA
聂纯一 et al. CLINICAL OBSERVATION ON THE EFFICACY OF 764-1 EYEDROPS IN TREATMENT OF CORNEAL SCARS